Showing results (1081-1090 of 6,768) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|January 21, 2014
Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysisPanayiotis D Ziakas, Irene S Kourbeti, Eleftherios MylonakisClinical Therapeutics|June 10, 2014
Intercellular communication by extracellular vesicles and their microRNAs in asthmaYu Fujita, Yusuke Yoshioka, Saburo Ito, et al.Clinical Therapeutics|November 6, 2012
Clinical overview of dalfampridine: an agent with a novel mechanism of action to help with gait disturbancesMichael D Egeberg, Caleb Y Oh, Jacquelyn L BainbridgeClinical Therapeutics|September 1, 1989
Effects of bunazosin on plasma glucose levels in hypertensive diabetic patientsN Takeda, T Iwai, A Tanamura, et al.Clinical Therapeutics|April 12, 2015
Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization ProtocolTetsuya Okayama, Takeshi Ishikawa, Kazuko Sugatani, et al.Clinical Therapeutics|April 14, 2015
Gastrointestinal Events Among Patients Initiating Osteoporosis Therapy: A Retrospective Administrative Claims Database AnalysisAnkita Modi, Ethel S Siris, Chun-Po Steve Fan, et al.Clinical Therapeutics|April 15, 2015
Statin Prescribing Patterns: An Analysis of Data From Patients With Diabetes in the National Hospital Ambulatory Medical Care Survey Outpatient Department and National Ambulatory Medical Care Survey Databases, 2005-2010Brandy R Pauff, Michael R Jiroutek, Melissa A Holland, et al.Clinical Therapeutics|March 10, 2015
Pharmacokinetics and tolerability of minodronic acid tablets in healthy Chinese subjects and food and age effects on the pharmacokineticsYing Zhou, Xiaomeng He, Huqun Li, et al.Clinical Therapeutics|March 22, 2015
Diabetes-Related Composite Quality End Point Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical TrialsRobert A Bailey, Ujjwala Vijapurkar, Gary Meininger, et al.Clinical Therapeutics|April 1, 2015
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in MelanomaKathleen M Mahoney, Gordon J Freeman, David F McDermottPageof 677